ACMR’s revenue beat is not the story; ownership dilution and gross-margin mix are the earnings power reset

The cleanest reading of this print is that expectations were set for a smaller revenue quarter with better earnings conversion, and ACMR delivered the opposite. What was priced in was $248.4 million of revenue and $0.47 of EPS. What actually surprised was $269.2 million of revenue, an +8.3% beat, alongside $0.36 of EPS, a -23.4% miss. That separation matters because the revenue beat was not just a timing artifact against a weak base: quarterly revenue was $269.2 million, with revenue YoY of +32.0% and revenue QoQ of +25.0%. But the earnings miss tells the PM where the debate moves next. Gross margin at 42.0% sat at the bottom edge of management’s model, operating expenses on the call basis were $76.9 million, up 56.3%, and net income per diluted share on the company’s call basis was $0.36 versus $0.63. The market may be missing that ACMR’s demand surprise and earnings disappointment are not contradictory. They are the same story: China tool demand is supporting revenue, while product mix, spending intensity, and parent-level ownership dilution are absorbing the upside before it reaches ACMR shareholders.

The revenue trajectory is still the part of the print that bulls can defend, and it is not trivial. Revenue moved from $172.3 million in Q1 FY2025 to $215.4 million in Q2 FY2025 and then $269.2 million in Q3 FY2025, with two consecutive quarters of revenue QoQ at +25.0%. The YoY line also reaccelerated from +13.2% in Q1 FY2025 and +6.4% in Q2 FY2025 to +32.0% in Q3 FY2025. Against a Street model looking for $248.4 million, the company beat by +8.3%, which is large enough to argue that demand recognition exceeded the buyside’s near-term caution. Management’s own call basis was consistent on the headline, with David Wang saying, “For the third quarter of 2025, we delivered revenue of $269 million, up 32% year-over-year.” The wording matters less for the number than for the absence of a caveat: management did not frame the revenue surge as a one-off pull-in, and the full-year range was narrowed rather than cut.

The margin line explains why the revenue chart is not a simple multiple-expansion argument. Gross margin of 42.0% was down from 48.5% in Q2 FY2025 and from 51.4% in Q3 FY2024, despite revenue rising to $269.2 million from $215.4 million sequentially and from $204.0 million year over year. That is the opposite of the operating leverage story investors wanted after an +8.3% revenue surprise. It puts Q3 FY2025 at the low end of the target model that Wang reaffirmed when he said, “There’s no change to our target model range of 42% to 48%.” The quote earns attention because it is both a reassurance and a warning: 42.0% is inside the range, but it is the floor of the range, so the burden of proof shifts to management to show that Q3 mix is not the new center of gravity. The recent history is not comforting enough to dismiss the risk. Gross margin was 47.9% in Q1 FY2025, 48.5% in Q2 FY2025, then 42.0% in Q3 FY2025. Revenue accelerated while margin compressed, which is exactly the combination that limits EPS follow-through.

That conversion problem gets sharper when the call-basis income items are put next to the Street miss. CFO Mark McKechnie said operating expenses were $76.9 million, up 56.3%, while operating income was $36.5 million, down 34.9%. He also said net income attributable to ACM Research was $24.8 million versus $42.4 million, and net income per diluted share was $0.36 versus $0.63. Those numbers reconcile the puzzle in the print: the company beat revenue by +8.3%, but EPS missed by -23.4% because incremental sales did not translate cleanly into incremental earnings. R&D is still planned in the 14% to 16% range, sales and marketing in the 8% range, and G&A in the 6% range for 2025. Those spending envelopes may be strategically rational if ACMR is building a broader platform, but they are not free. The stock should not be valued on revenue acceleration alone when operating expenses are up 56.3% and operating income is down 34.9%.

The ownership change is the second layer of the earnings-quality reset, and it is the piece most likely to be under-modeled by investors focused on shipment and revenue momentum. McKechnie reminded analysts that after the second capital raise of $632 million net by the subsidiary, ACM’s ownership in ACM Shanghai is now 74.6% versus 81.1% at the end of last quarter. That is a direct claim on the economics that matter to ACMR holders. The capital raise also transformed the balance sheet optics: cash and cash equivalents, restricted cash and time deposits were $1.1 billion at the end of the third quarter versus $483.9 million at the end of the second quarter, and net cash was $811 million, or about $12 per share, versus $205.8 million at the end of the second quarter. The variant perception is that the market will be tempted to capitalize the $811 million net cash improvement, but the same transaction reduced ACM’s ownership to 74.6%. Balance sheet de-risking and per-share earnings dilution arrived together, and a proper multiple has to reflect both.

The shipment detail supports the idea that demand is real, but it also prevents a clean celebration of the revenue beat. On the call basis, total shipments were $263.1 million, up 28% sequentially and up 0.7% year-over-year, while David Wang separately said shipments were $263 million, up 1% year-over-year. The two shipment phrasings differ only in precision, and both imply that revenue growth of +32.0% was far ahead of year-over-year shipment growth. That does not invalidate the quarter, because revenue recognition and shipment timing can diverge, but it does raise the confirmation threshold for Q4. Inventory net was $676.4 million versus $648.3 million at the end of the second quarter, and cash flow used by operations was $4.6 million for the third quarter and $44.4 million year-to-date. A company with $269.2 million of quarterly revenue, $676.4 million of inventory net, and year-to-date cash flow used by operations of $44.4 million is not yet proving that scale has turned into working-capital efficiency. It is proving that the demand funnel requires capital.

That capital requirement links directly to capacity, where management is clearly building for a much larger company than the one implied by Q3 revenue. Wang said the two buildings can support up to $3 billion in annual output, and he reiterated a long-term revenue target of $4 billion, with an estimated $2.5 billion contribution from China and $1.5 billion from global markets. He also described tools that run around $50,000 to $1 million each across coder, developer, etcher, steeper and wafer-level packaging. The spending plan is consistent with that ambition: 2025 capital expenditures are expected at about $60 million to $70 million. The problem for the stock is timing, not ambition. A $3 billion annual output footprint and a $4 billion long-term revenue target can create strategic value, but Q3 FY2025 showed gross margin at 42.0%, operating income down 34.9%, and parent ownership at 74.6%. The market may be too quick to discount the target revenue base without applying a lower confidence factor to the margin and ownership path.

The customer read-through is most important for SMIC, because the supply-chain table identifies SMIC as a customer for single-wafer cleaning through SAPS and TEBO. ACMR’s Q3 revenue of $269.2 million and revenue YoY of +32.0% show that domestic China cleaning demand is still converting into recognized sales, but shipments of $263.1 million up only 0.7% year-over-year keep the customer implication narrower than the revenue headline. For SMIC, the read-through is positive for ongoing tool localization and installed-base support in cleaning, not necessarily for a broad acceleration in incremental fab equipment receipts. Wang’s statement that ACMR estimates an incremental opportunity of more than $1 billion for new cleaning products from the Mainland China market alone, and that the company remains confident in a target for 60% market share in China, frames the strategic threat to incumbent cleaning suppliers. The magnitude is the point: more than $1 billion of Mainland China opportunity and a 60% share target imply ACMR is not treating cleaning as a niche attach market. For suppliers, the data pack lists none, so there is no named upstream read-through to force.

The peer comparison also supports a nuanced view: ACMR is growing faster than most listed wafer-fab-equipment peers in the table, but it is not earning a premium gross-margin profile this quarter. ACMR’s revenue YoY was +32.0%, above 6728.T at +28.2%, 6361.T at +15.8%, TOELY at +10.6%, 7735.T at +9.1%, 7751.T at +3.3%, 6302.T at 0.0%, 6525.T at -3.5%, and 7731.T at -4.6%. On gross margin, however, ACMR’s 42.0% trails TOELY at 46.8% and 7751.T at 46.2%, while sitting ahead of 7731.T at 40.5%, 7735.T at 40.8%, 6525.T at 39.4%, 6728.T at 32.0%, 6361.T at 31.6%, and 6302.T at 25.0%. The right comparative point is not that ACMR lacks growth. It has the highest revenue YoY in this peer set at +32.0%. The issue is that the quarter did not translate that growth into a best-in-class margin outcome, so the premium argument needs evidence that 42.0% is temporary rather than the price of winning domestic share.

The call delivery reinforces that this was a more cautious quarter than the revenue headline alone suggests, and the tone history is unusually useful here because the numbers moved in different directions. Q3 FY2025 sentiment was 0.27, down from 0.37 in Q2 FY2025, while guidance_tone was 0.11, down from 0.12. Prepared_sentiment stayed elevated at 0.53 versus 0.55 in Q2 FY2025, but qa_sentiment fell to 0.00 from 0.28, ai_optimism fell to 0.36 from 0.44, uncertainty rose to 95.9 from 85.7, and qa_evasiveness rose to 40.5 from 30.7. That split is the call version of the financial print: the prepared message carried the long-term plan, while the Q&A tone deteriorated as analysts pressed on the moving parts. The one piece of wording that did signal discipline was Wang’s guidance update: “We have narrowed our 2025 revenue outlook to a range of USD 875 million to $925 million versus prior range of $850 million to $950 million.” Narrowing the range rather than lowering it reduces top-line risk for 2025, but it does not answer the EPS question raised by the -23.4% surprise.

The guidance range makes the stock a debate about revenue visibility versus earnings capture into year-end. A 2025 revenue outlook of $875 million to $925 million implies management still sees enough backlog, shipment conversion, and customer demand to support 10% to 15% revenue growth. That is why a bearish interpretation based solely on the EPS miss is too simple. The company has $1.1 billion of cash and cash equivalents, restricted cash and time deposits, net cash of $811 million, a $60 million to $70 million capital expenditure plan, and capacity that management says can support up to $3 billion in annual output. Those numbers reduce financing risk and support the strategic plan. But a bullish interpretation based solely on the revenue beat is also too simple. Gross margin was 42.0%, operating expenses were $76.9 million, operating income was down 34.9%, and ACM’s ownership in ACM Shanghai was 74.6%. The revenue model got less risky this quarter, while the per-share earnings model got more complicated.

What to watch next is therefore precise. First, gross margin must move off the 42.0% floor of the 42% to 48% target model; another quarter at or near 42.0% would confirm that share gains and mix are diluting revenue quality. Second, the next revenue print should be judged against the narrowed 2025 revenue outlook of $875 million to $925 million, not just against consensus, because management has taken the range in from $850 million to $950 million. Third, shipments need to close the gap with recognized revenue: Q3 shipments were $263.1 million, up 28% sequentially but only up 0.7% year-over-year, while revenue was $269.2 million and up +32.0% YoY. Fourth, monitor cash conversion against inventory net of $676.4 million and cash flow used by operations of $44.4 million year-to-date; a growth company can carry inventory, but it cannot ask investors to ignore it while EPS misses by -23.4%. Finally, any update after 2025-11-05 on ACM Shanghai ownership should be treated as an earnings-power item, not a footnote, because the move to 74.6% is the clearest reason this revenue beat should not be bought mechanically.